Pharma & Life Sciences

Vaccines to Treat Opiate Addiction

Feature Image Source: https://www.flickr.com/photos/yanivba/505065706

In the second part of this series on Opioids, our blogger analyzes popular medication to treat withdrawal symptoms from opiates, and associated patented medication. Opioids have been used for centuries as a drug for treating pain. However, despite their benefits, many opiate drugs are married to the side-effect of addiction. Since a few medical conditions demand the need for opiate […]

From Addiction to Wonder Drug, Will Opioids Win this Battle?

Featured image source: http://maxpixel.freegreatpicture.com/Garden-Poppy-Raw-Pods-Papaver-Capsules-Opium-87112

Pain treatment is a subject that has garnered ample attention from the medical fraternity since the days of recorded medical history. From the times of Sushruta till the era of IoT, treating pain in its various formats has kept researchers’ interest alive. Opium in its natural and synthetic forms has been used in the past to treat pain. Opiate, an […]

Is it a must-win for Biogen over Forward Pharma?

Featured image source: https://www.pexels.com/photo/dark-purple-black-medicine-119931/

Biogen has had a news-breaking start to the year, first with Michael Vounatsos taking over as the CEO of the company; and second, with Vounatsos announcing a payout of $1.25 billion to Forward Pharma to settle a patent licensing agreement. Vounatos has been quoted in the media as saying this will help strengthen Biogen’s intellectual property and protect its drug […]

Protein Sequence Analysis: An Essential Tool for Innovation

Featured image source: https://commons.wikimedia.org/wiki/File:Docking.jpg

“Knowledge of sequences could contribute much to our understanding of living matter.” – Frederick Sanger, Nobel Laureate & biotechnologist Patenting protein sequences has been a subject of much contention. It often carries the burden of being governed by the doctrine of equivalents, despite the fact that there is an increasing number of modified proteins being created by pharmaceutical companies with […]

Decoding India’s Section 3(d) Pharma Controversy

Source: http://tabletkinaodchudzanie.bblog.pl/i/blog/users/158355/files/Image/14.jpg

India owns the third largest pharmaceutical industry in the world in terms of volume and is the 14th largest in terms of value. It has joined hands with those of China, Brazil, Russia and 13 other countries to create a pool of pharmerging countries. This pool is expected to contribute nearly 50% of the world’s annual pharmaceutical market growth. While India […]

Deuterated Drugs set to Explode in Patent Battles

Source: http://www.farmaceuticas.com.br/wp-content/uploads/2014/11/formula.jpg

Circa 2015 created a flutter of excitement in the pharmaceutical world when scientists unearthed patents filed in the 1970s and found it supporting the claims of a modified drug manufactured in the USA. The SD-809 drug is a deuterated drug that is awaiting the FDA’s approval to get on shelves and help cure palsy in patients affected by Huntington’s chorea. […]